Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2007, Article ID 14983, 12 pages
http://dx.doi.org/10.1155/2007/14983
Review Article

Peroxisome Proliferator Activated Receptor Ligands as Regulators of Airway Inflammation and Remodelling in Chronic Lung Disease

Department of Pharmacology, University of Melbourne, Victoria 3010, Australia

Received 27 April 2007; Accepted 11 June 2007

Academic Editor: Theodore J. Standiford

Copyright © 2007 Jane Elizabeth Ward and Xiahui Tan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [35 citations]

The following is the list of published articles that have cited the current article.

  • Jane E. Ward, and Stuart J. Hirstpp. 105–126, 2008. View at Publisher · View at Google Scholar
  • David J. Cousins, Joanne McDonald, and Tak H. Lee, “Therapeutic approaches for control of transcription factors in allergic disease,” Journal of Allergy and Clinical Immunology, vol. 121, no. 4, pp. 803–809, 2008. View at Publisher · View at Google Scholar
  • Attila Szanto, and Laszlo Nagy, “The many faces of PPARγ: Anti-inflammatory by any means?,” Immunobiology, vol. 213, no. 9-10, pp. 789–803, 2008. View at Publisher · View at Google Scholar
  • Masamichi Yamashita, “PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells,” PPAR Research, vol. 2008, pp. 1–6, 2008. View at Publisher · View at Google Scholar
  • Jouneau, “Therapeutic updates in COPD,” Revue des Maladies Respiratoires Actualites, vol. 1, no. 5, pp. 509–514, 2009. View at Publisher · View at Google Scholar
  • Terence Peters, and Peter J Henry, “Protease-activated receptors and prostaglandins in inflammatory lung disease,” British Journal of Pharmacology, vol. 158, no. 4, pp. 1017–1033, 2009. View at Publisher · View at Google Scholar
  • Royce, and Tang, “The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention,” Current Molecular Pharmacology, vol. 2, no. 2, pp. 169–181, 2009. View at Publisher · View at Google Scholar
  • Duncan B. Richards, Philippe Bareille, Emma L. Lindo, Dean Quinn, and Stuart N. Farrow, “Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial,” Respiratory Medicine, vol. 104, no. 5, pp. 668–674, 2010. View at Publisher · View at Google Scholar
  • L.-R. Chen, S.-C. Lee, Y.-P. Lin, Y.-L. Hsieh, Y.-L. Chen, J.-R. Yang, J.-F. Liou, C.-F. Chen, Y.-P. Lee, and Y.-L. Shiue, “Prostaglandin-D synthetase induces transcription of the LH beta subunit in the primary culture of chicken anterior pituitary cells via the PPAR signaling pathway,” Theriogenology, vol. 73, no. 3, pp. 367–382, 2010. View at Publisher · View at Google Scholar
  • Xiahui Tan, Hayat Dagher, Craig A. Hutton, and Jane E. Bourke, “Effects of PPAR gamma ligands on TGF-beta 1-induced epithelial-mesenchymal transition in alveolar epithelial cells,” Respiratory Research, vol. 11, 2010. View at Publisher · View at Google Scholar
  • Sheila G. Haworth, Lucie H. Clapp, Emilia Falcetti, Susan M. Hall, Peter G. Phillips, Jigisha Patel, and Nicholas W. Morrell, “Smooth Muscle Proliferation and Role of the Prostacyclin (IP) Receptor in Idiopathic Pulmonary Arterial Hypertension,” American Journal Of Respiratory And Critical Care Medicine, vol. 182, no. 9, pp. 1161–1170, 2010. View at Publisher · View at Google Scholar
  • Yong Sung Park, Wei Guang, Thomas G. Blanchard, K. Chul Kim, and Erik P. Lillehoj, “Suppression of IL-8 production in gastric epithelial cells by MUC1 mucin and peroxisome proliferator-associated receptor-γ,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 303, no. 6, pp. G765–G774, 2012. View at Publisher · View at Google Scholar
  • Yong Sung Park, Erik P. Lillehoj, Kosuke Kato, Choon Sik Park, and Kwang Chul Kim, “PPAR gamma inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism,” American Journal Of Physiology-Lung Cellular And Molecular Physiology, vol. 302, no. 7, pp. 1679–1687, 2012. View at Publisher · View at Google Scholar
  • Istvan Szatmari, Lajos Szeles, Laszlo Nagy, and Attila Szanto, “Nuclear Hormone Receptors Enable Macrophages And Dendritic Cells To Sense Their Lipid Environment And Shape Their Immune Response,” Physiological Reviews, vol. 92, no. 2, pp. 739–789, 2012. View at Publisher · View at Google Scholar
  • Sesquile Ramon, Simona Bancos, Thomas H. Thatcher, Thomas I. Murant, Safiehkhatoon Moshkani, Julie M. Sahler, Andrea Bottaro, Patricia J. Sime, and Richard P. Phipps, “Peroxisome proliferator-activated receptor γ b cell-specific- deficient mice have an impaired antibody response,” Journal of Immunology, vol. 189, no. 10, pp. 4740–4747, 2012. View at Publisher · View at Google Scholar
  • Yongchun Shen, Lei Chen, Tao Wang, and Fuqiang Wen, “PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases,” PPAR Research, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Chantal Donovan, Xiahui Tan, and Jane Elizabeth Bourke, “PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy,” PPAR Research, vol. 2012, pp. 1–13, 2012. View at Publisher · View at Google Scholar
  • Hui-Fang Kao, Pei-Wen Chang-Chien, Wen-Tsan Chang, Trai-Ming Yeh, and Jiu-Yao Wang, “Propolis inhibits TGF-beta 1-induced epithelial-mesenchymal transition in human alveolar epithelial cells via PPAR gamma activation,” International Immunopharmacology, vol. 15, no. 3, pp. 565–574, 2013. View at Publisher · View at Google Scholar
  • Jihan A. Youssef, Mostafa Z. Badr, Jihan A. Youssef, and Mostafa Z. Badr, “Tissue Distribution and Versatile Functions of PPARs,” Peroxisome Proliferator-Activated Receptors, pp. 33–69, 2013. View at Publisher · View at Google Scholar
  • Jihan A. Youssef, and Mostafa Z. Badrpp. 1–137, 2013. View at Publisher · View at Google Scholar
  • Victor Kim, Kosuke Kato, K. Chul Kim, and Erik P. Lillehojpp. 81–98, 2013. View at Publisher · View at Google Scholar
  • Hassan Malekinejad, Masoud Mehrabi, Mona Khoramjouy, and Ali Rezaie-Golmisheh, “Antifibrotic effect of Atorvastatin on Paraquat-induced pulmonary fibrosis: Role of PPAR γ receptors,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Bogdan Jakiela, Anna Gielicz, Hanna Plutecka, Magdalena Hubalewska, Lucyna Mastalerz, Grazyna Bochenek, Jerzy Soja, Rafal Januszek, Jacek Musial, and Marek Sanak, “Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells,” Prostaglandins & Other Lipid Mediators, vol. 106, pp. 116–123, 2013. View at Publisher · View at Google Scholar
  • Jane E. Bourke, Yan Bai, Chantal Donovan, James G. Esposito, Xiahui Tan, and Michael J. Sanderson, “Novel Small Airway Bronchodilator Responses to Rosiglitazone in Mouse Lung Slices,” American Journal of Respiratory Cell and Molecular Biology, vol. 50, no. 4, pp. 748–756, 2014. View at Publisher · View at Google Scholar
  • Siva Kumar Solleti, Dawn M. Simon, Sorachai Srisuma, Meltem C. Arikan, Soumyaroop Bhattacharya, Tirumalai Rangasamy, Kaiser M. Bijli, Arshad Rahman, Joseph T. Crossno, Steven D. Shapiro, and Thomas J. Mariani, “Airway epithelial cell PPAR gamma modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice,” American Journal Of Physiology-Lung Cellular And Molecular Physiology, vol. 309, no. 3, pp. L293–L304, 2015. View at Publisher · View at Google Scholar
  • Jignesh K. Nagar, Praful P. Patel, Jogeswar N. Mohapatra, Manoranjan M. Sharma, Gaurav M. Pandya, Malik M. Umar, Abhijit A. Chatterjee, Shrikalp S. Deshpande, Mukul R. Jain, and Hitesh M. Soni, “Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: Possible role of tissue inhibitor of,” Indian Journal Of Pharmacology, vol. 47, no. 2, pp. 153–159, 2015. View at Publisher · View at Google Scholar
  • Krisztian Kvell, and Judit E. Pongracz, “Immunosenescence and the Ageing Lung,” The Ageing Immune System and Health, pp. 87–104, 2016. View at Publisher · View at Google Scholar
  • Maryann Kaler, Amisha V. Barochia, Nargues A. Weir, Rosemarie A. Cuento, Mario Stylianou, Mark J. Roth, Armando C. Filie, Ellen C. Vaughey, Steven D. Nathan, and Stewart J. Levine, “A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma,” Journal of Allergy and Clinical Immunology, 2017. View at Publisher · View at Google Scholar
  • Diego S. Coutinho, Edna A. Anjos-Valotta, Caio V. M. F. do Nascimento, Ana Lucia A. Pires, Marcelo H. Napimoga, Vin?cius F. Carvalho, Rafael C. Torres, Patr?cia M. R. e Silva, and Marco A. Martins, “15-Deoxy-Delta-12,14-Prostaglandin J2 Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Hsin-Hsien Li, Hsao-Hsun Hsu, Gwo-Jyh Chang, I-Chen Chen, Wan-Jing Ho, Pei-Chen Hsu, Wei-Jan Chen, Jong-Hwei Su Pang, Chung-Chi Huang, and Ying-Ju Lai, “Prostanoid EP4 Agonist L-902,688 Activates PPARγ and Attenuates Pulmonary Arterial Hypertension,” American Journal of Physiology-Lung Cellular and Molecular Physiology, pp. ajplung.00245.2, 2017. View at Publisher · View at Google Scholar
  • Sowmya P. Lakshmi, Aravind T. Reddy, Asoka Banno, and Raju C. Reddy, “PPAR Agonists for the Prevention and Treatment of Lung Cancer,” PPAR Research, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Sowmya P. Lakshmi, Aravind T. Reddy, Asoka Banno, and Raju C. Reddy, “Airway Epithelial Cell Peroxisome Proliferator–Activated Receptor γ Regulates Inflammation and Mucin Expression in Allergic Airway Disease,” The Journal of Immunology, vol. 201, no. 6, pp. 1775–1783, 2018. View at Publisher · View at Google Scholar
  • Asoka Banno, Aravind T. Reddy, Sowmya P. Lakshmi, and Raju C. Reddy, “PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma,” Nuclear Receptor Research, vol. 5, 2018. View at Publisher · View at Google Scholar
  • Ryan D. Jones, Jie Liao, Xin Tong, Dandan Xu, Leyu Sun, Haonan Li, and Guang-Yu Yang, “Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis,” Frontiers in Pharmacology, vol. 10, 2019. View at Publisher · View at Google Scholar
  • Honglei Zhang, Lin You, and Min Zhao, “Rosiglitazone attenuates paraquat-induced lung fibrosis in rats in a PPAR gamma-dependent manner,” European Journal of Pharmacology, 2019. View at Publisher · View at Google Scholar